Novartis AG makers of Tasigna Failed to Warn Public of the Dangerous Side Effects

Tasigna a drug used to treat advanced cancer patients and the makers Novartis AG under fire in a St Louis court of law

Friday, July 14, 2017 - Tens of thousands of Americans have been given dangerous anti-cancer chemotherapy drug Tasigna without their knowing about the drug's deadly side effects. The maker of Tasigna, Swiss Pharmaceutical giant Novartis AG, was informed of these side effects, specifically the linkage between using Tasigna and developing peripheral artery disease, immediately when such knowledge became available in 2011, yet failed to warn American oncologists, cancer doctors or other concerned parties in the medical community and as a result thousands of unsuspecting Americans have either died or have had to suffer strokes, heart attacks and amputation of toes, feet and even an entire leg. If you are one of those people who have suffered at the hands of Novartis, or if you have a loved one who died as a result of peripheral artery disease after taking Tasigna chemotherapy treatments, you may file a lawsuit and seek compensation for your medical expenses, lost wages, pain and suffering and a large punitive damages.

Philadelphia chromosome-positive myeloid leukemia is another name for bone marrow or blood cancer and occurs when the bone marrow overproduces immature white blood cells. These immature white blood cells do not function properly and crowd out other normal healthy blood cells. Symptoms of myeloid leukemia are constantly feeling fatigued, easy bruising or bleeding, unexplained weight loss and joint and bone pain. Myeloid leukemia is easily detected by a routine blood test by an excessive white blood cell count. People with myeloid leukemia in its most advanced stages are given Tasigna which has proven to be even more deadly than the disease it was originally intended to cure.

Tasigna is approved for use in 110 countries around the world yet the side effects are immense. Tasigna has been ordered to include the sternest of warnings, the boxed warning, that using the drug can cause sudden death. The company's website warns of the possibilities of heart disease developing or becoming critically worsened as well, stating, "Cardiovascular events, including arterial vascular occlusive events, were reported in a randomized, clinical trial in newly diagnosed Ph+ CML patients and observed in the post-marketing reports of patients receiving nilotinib therapy (Tasigna). Cases of cardiovascular events included ischemic heart disease-related events, peripheral arterial occlusive disease, and ischemic cerebrovascular events.

A peer-reviewed study of Tasigna published in the American Journal of Hematology indicated that according to clinical data, 16% of Tasigna patients developed PAD. The American Food and Drug Association has cited this study and others when stating that a peripheral artery disease warning should be added to the drug's packaging and labeling. Although Canadian health officials were warned and the Canadian medical community alerted as to the dangers of Tasigna, no such warning made its way to the multi-billion dollar Tasigna market in the United States.

If you have developed peripheral artery disease or have a loved one who has died from the deadly side effects of taking Tasigna anti-cancer chemotherapy treatment, call our law firm for a free consultation. There is no cost unless we win your case and recover damages.

More Recent Tasigna Atherosclerosis Lawsuit News:

Lawyers for Tasigna Atherosclerosis Lawsuits

Attorneys handling Tasigna lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Tasigna lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Tasigna lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.